Replies to post #13693 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>Would Leo be a possibility?<

I can’t rule it out but it strikes me as unlikely. I would expect more interest from companies who want to establish an early foothold in the US FoB market.